Literature DB >> 24390199

COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy.

Bence Gunda1, Manuele Mine, Tibor Kovács, Csilla Hornyák, Dániel Bereczki, György Várallyay, Gábor Rudas, Marie-Pierre Audrezet, Elisabeth Tournier-Lasserve.   

Abstract

Type IV collagen α1 and α2 chains form heterotrimers that constitute an essential component of basement membranes. Mutations in COL4A1, encoding the α1 chain, cause a multisystem disease with prominent cerebrovascular manifestations, including porencephaly, bleeding-prone cerebral small vessel disease, and intracranial aneurysms. Mutations in COL4A2 have only been reported in a few porencephaly families so far. Herein, we report on a young adult patient with recurrent intracerebral hemorrhage, leukoencephalopathy, intracranial aneurysms, nephropathy, and myopathy associated with a novel COL4A2 mutation. We extensively investigated a 29-year-old male patient with recurrent deep intracerebral hemorrhages causing mild motor and sensory hemisyndromes. Brain MRI showed deep intracerebral hemorrhages of different age, diffuse leukoencephalopathy, multiple cerebral microbleeds and small aneurysms of the carotid siphon bilaterally. Laboratory work-up revealed significant microscopic hematuria and elevation of creatine-kinase. Genetic testing found a de novo glycine mutation within the COL4A2 triple helical domain. The presented case completes the spectrum of cerebral and systemic manifestations of COL4A2 mutations that appears to be very similar to that in COL4A1 mutations. Therefore, we emphasize the importance of screening both COL4A1 and COL4A2 in patients showing recurrent intracerebral hemorrhage of unknown etiology, particularly if associated with leukoencephalopathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390199     DOI: 10.1007/s00415-013-7224-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  Ophthalmological features associated with COL4A1 mutations.

Authors:  Isabelle Coupry; Igor Sibon; Bruno Mortemousque; François Rouanet; Manuele Mine; Cyril Goizet
Journal:  Arch Ophthalmol       Date:  2010-04

2.  De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly.

Authors:  Yuriko Yoneda; Kazuhiro Haginoya; Hiroshi Arai; Shigeo Yamaoka; Yoshinori Tsurusaki; Hiroshi Doi; Noriko Miyake; Kenji Yokochi; Hitoshi Osaka; Mitsuhiro Kato; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Am J Hum Genet       Date:  2011-12-29       Impact factor: 11.025

3.  COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke.

Authors:  Marion Jeanne; Cassandre Labelle-Dumais; Jeff Jorgensen; W Berkeley Kauffman; Grazia M Mancini; Jack Favor; Valerie Valant; Steven M Greenberg; Jonathan Rosand; Douglas B Gould
Journal:  Am J Hum Genet       Date:  2011-12-29       Impact factor: 11.025

4.  COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage.

Authors:  Katayoun Vahedi; Nathalie Kubis; Monique Boukobza; Minh Arnoult; Pascale Massin; Elisabeth Tournier-Lasserve; Marie-Germaine Bousser
Journal:  Stroke       Date:  2007-03-22       Impact factor: 7.914

Review 5.  Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease.

Authors:  Katayoun Vahedi; Sonia Alamowitch
Journal:  Curr Opin Neurol       Date:  2011-02       Impact factor: 5.710

6.  Role of COL4A1 in small-vessel disease and hemorrhagic stroke.

Authors:  Douglas B Gould; F Campbell Phalan; Saskia E van Mil; John P Sundberg; Katayoun Vahedi; Pascale Massin; Marie Germaine Bousser; Peter Heutink; Jeffrey H Miner; Elisabeth Tournier-Lasserve; Simon W M John
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

Review 7.  COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review.

Authors:  Silvia Lanfranconi; Hugh S Markus
Journal:  Stroke       Date:  2010-06-17       Impact factor: 7.914

8.  COL4A2 mutation associated with familial porencephaly and small-vessel disease.

Authors:  Elly Verbeek; Marije E C Meuwissen; Frans W Verheijen; Paul P Govaert; Daniel J Licht; Debbie S Kuo; Cathryn J Poulton; Rachel Schot; Maarten H Lequin; Jeroen Dudink; Dicky J Halley; René I F de Coo; Jan C den Hollander; Renske Oegema; Douglas B Gould; Grazia M S Mancini
Journal:  Eur J Hum Genet       Date:  2012-02-15       Impact factor: 4.246

9.  COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.

Authors:  Emmanuelle Plaisier; Olivier Gribouval; Sonia Alamowitch; Béatrice Mougenot; Catherine Prost; Marie Christine Verpont; Béatrice Marro; Thomas Desmettre; Salomon Yves Cohen; Etienne Roullet; Michel Dracon; Michel Fardeau; Tom Van Agtmael; Dontscho Kerjaschki; Corinne Antignac; Pierre Ronco
Journal:  N Engl J Med       Date:  2007-12-27       Impact factor: 91.245

Review 10.  COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.

Authors:  Debbie S Kuo; Cassandre Labelle-Dumais; Douglas B Gould
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

View more
  16 in total

1.  Identification of crucial genes in intracranial aneurysm based on weighted gene coexpression network analysis.

Authors:  X Zheng; C Xue; G Luo; Y Hu; W Luo; X Sun
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

2.  Basement membrane and stroke.

Authors:  Yao Yao
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-18       Impact factor: 6.200

Review 3.  Monogenic causes of stroke: now and the future.

Authors:  Rhea Y Y Tan; Hugh S Markus
Journal:  J Neurol       Date:  2015-06-03       Impact factor: 4.849

4.  'De novo' Col4A2 mutation in a patient with migraine, leukoencephalopathy, and small carotid aneurysms.

Authors:  Paul Kollmann; André Peeters; Olivier Vanakker; Yves Sznajer
Journal:  J Neurol       Date:  2016-09-13       Impact factor: 4.849

Review 5.  Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations.

Authors:  Marion Jeanne; Douglas B Gould
Journal:  Matrix Biol       Date:  2016-10-26       Impact factor: 11.583

Review 6.  Headache and acute stroke.

Authors:  Dara G Jamieson; Natalie T Cheng; Maryna Skliut
Journal:  Curr Pain Headache Rep       Date:  2014-09

7.  Fgfbp1 promotes blood-brain barrier development by regulating collagen IV deposition and maintaining Wnt/β-catenin signaling.

Authors:  Azzurra Cottarelli; Monica Corada; Galina V Beznoussenko; Alexander A Mironov; Maria A Globisch; Saptarshi Biswas; Hua Huang; Anna Dimberg; Peetra U Magnusson; Dritan Agalliu; Maria Grazia Lampugnani; Elisabetta Dejana
Journal:  Development       Date:  2020-08-24       Impact factor: 6.868

8.  Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.

Authors:  Marion Jeanne; Jeff Jorgensen; Douglas B Gould
Journal:  Circulation       Date:  2015-03-09       Impact factor: 29.690

Review 9.  Imaging Endophenotypes of Stroke as a Target for Genetic Studies.

Authors:  Xueqiu Jian; Myriam Fornage
Journal:  Stroke       Date:  2018-05-14       Impact factor: 7.914

10.  Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?-a microarray analysis based on regional population.

Authors:  Zhijun Feng; Ruili Qiao; Zhijian Ren; Xiaofeng Hou; Jie Feng; Xiaodong He; Dongdong Chen
Journal:  J Gastrointest Oncol       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.